Average Co-Inventor Count = 5.17
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Smithkline Beecham Corporation (7 from 2,198 patents)
2. Glaxo Group Limited (3 from 1,168 patents)
3. Glaxo Wellcome Inc. (3 from 281 patents)
13 patents:
1. 7432289 - 5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
2. 7425555 - Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
3. 7208629 - 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
4. 7166623 - 2'-Methyl-5′-(1,3,4-oxadiazol-2-yl)-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
5. 7109333 - Heterocyclic compounds
6. 6828320 - Heterocyclic compounds
7. 6727256 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
8. 6723726 - Protein tyrosine kinase inhibitors
9. 6713485 - Heterocyclic compounds
10. 6391874 - Fused heterocyclic compounds as protein tyrosine kinase inhibitors
11. 6207669 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
12. 6174889 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
13. 6169091 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors